Search Results - "Svarstad, E"

Outcome in biopsy-proven Lupus nephritis: Evaluation of biopsies from the Norwegian Kidney Biopsy Registry by Norby, G E, Mjøen, G, Bjørneklett, R, Vikse, B E, Holdaas, H, Svarstad, E, Aasarød, K

“…Objective To evaluate long-term mortality and end-stage renal disease (ESRD) in a cohort of Norwegian patients with biopsy-proven lupus nephritis (LN). Methods…”
Get full text

Renal outcomes of agalsidase beta treatment for Fabry disease: role of proteinuria and timing of treatment initiation by WARNOCK, David G, ORTIZ, Alberto, LEMAY, Roberta, COLE, J. Alexander, SVARSTAD, Einar, WALDEK, Stephen, GERMAIN, Dominique P, WANNER, Christoph, MAUER, Michael, LINTHORST, Gabor E, OLIVEIRA, Joao P, SERRA, Andreas L, MARODI, László, MIGNANI, Renzo, VUJKOVAC, Bojan, BEITNER-JOHNSON, Dana

“…The purpose of this study was to identify determinants of renal disease progression in adults with Fabry disease during treatment with agalsidase beta. Renal…”
Get full text

Scoring system for renal pathology in Fabry disease: report of the International Study Group of Fabry Nephropathy (ISGFN) by Fogo, Agnes B., Bostad, Leif, Svarstad, Einar, Cook, William J., Moll, Solange, Barbey, Federic, Geldenhuys, Laurette, West, Michael, Ferluga, Dusan, Vujkovac, Bojan, Howie, Alexander J., Burns, Áine, Reeve, Roy, Waldek, Stephen, Noël, Laure-Hélène, Grünfeld, Jean-Pierre, Valbuena, Carmen, Oliveira, João Paulo, Müller, Justus, Breunig, Frank, Zhang, Xiao, Warnock, David G.

“…Background. In Fabry nephropathy, alpha-galactosidase deficiency leads to accumulation of glycosphingolipids in all kidney cell types, proteinuria and…”
Get full text

Standardising clinical outcomes measures for adult clinical trials in Fabry disease: A global Delphi consensus by Moreno-Martinez, D., Aguiar, P., Auray-Blais, C., Beck, M., Bichet, D.G., Burlina, A., Cole, D., Elliott, P., Feldt-Rasmussen, U., Feriozzi, S., Fletcher, J., Giugliani, R., Jovanovic, A., Kampmann, C., Langeveld, M., Lidove, O., Linhart, A., Mauer, M., Moon, J.C., Muir, A., Nowak, A., Oliveira, J.P., Ortiz, A., Pintos-Morell, G., Politei, J., Rozenfeld, P., Schiffmann, R., Svarstad, E., Talbot, A.S., Thomas, M., Tøndel, C., Warnock, D., West, M.L., Hughes, D.A.

“…Recent years have witnessed a considerable increase in clinical trials of new investigational agents for Fabry disease (FD). Several trials investigating…”
Get full text

Polyvinylpyrrolidone induced artefactual prolongation of activated partial thromboplastin times in intravenous drug users with renal failure by Kristoffersen, A. H., Bjånes, T. K., Jordal, S., Leh, S., Leh, F., Svarstad, E.

“…Essentials Prolonged activated partial thromboplastin times (APTT) were found in drug users with renal failure. An oral methadone solution containing…”
Get full text

Phenotypic variation in a large family with autosomal dominant hypocalcaemia by Sørheim, J I, Husebye, E S, Nedrebø, B G, Svarstad, E, Lind, J, Boman, H, Løvås, K

“…Autosomal dominant hypocalcaemia (ADH) is caused by activating mutations in the calcium- sensing receptor (CASR). We aimed to describe the phenotypic variation…”
Get more information

The MDRD equation may mask decline of glomerular filtration rate in Fabry patients with normal or nearly normal kidney function by Aakre, K M, Tøndel, C, Brun, A, Svarstad, E

“…The renal prognosis in Fabry disease is better when enzyme replacement therapy (ERT) is initiated before glomerular filtration rate (GFR) deteriorates. Current…”
Get more information

A mother and daughter with unexplained renal failure by Christiansen, R E, Fiskerstrand, T, Leh, S, Haukanes, B I, Singh, A K, Fervenza, F C, Svarstad, E

Get more information

Bedside stereomicroscopy of renal biopsies may lead to a rapid diagnosis of Fabry's disease by Svarstad, Einar, Iversen, Bjarne M., Bostad, Leif

Get full text

Critical renal artery stenoses may cause a spectrum of cardiorenal failure and associated thromboembolic events by Svarstad, E, Urheim, L, Iversen, B M

“…A wide spectrum of acute or chronic heart failure and thromboembolic events may be causally related to high-grade uni- or bilateral renovascular hypertensive…”
Get more information

Factors influencing reduction in blood pressure and left ventricular mass in hypertensive type-1 diabetic patients using captopril or doxazosin for 6 months by Gerdts, E., Svarstad, E., Aanderud, S., Myking, O.L., Lund-Johansen, P., Omvik, P.

“…The effect of doxazosin versus captopril on blood pressure, albuminuria, and left ventricular mass was studied in 33 hypertensive type-1 diabetic patients…”
Get full text

SUN-135 DEVELOPING NEPHROLOGY SERVICES IN LOW INCOME COUNTRIES: A CASE OF TANZANIA by Fredrick Furia, F., Shoo, J., Ruggajo, J.P., Kilonzo, K., Basu, G., Yeates, K., Varughese, S., Svarstad, E., Kisanga, O.

Get full text

Reduced α-galactosidase A activity in zebrafish (Danio rerio) mirrors distinct features of Fabry nephropathy phenotype by Elsaid, Hassan O.A., Furriol, Jessica, Blomqvist, Maria, Diswall, Mette, Leh, Sabine, Gharbi, Naouel, Anonsen, Jan Haug, Babickova, Janka, Tøndel, Camilla, Svarstad, Einar, Marti, Hans-Peter, Krause, Maximilian

“…Fabry disease (FD) is a rare genetic lysosomal storage disorder, resulting from partial or complete lack of alpha-galactosidase A (α-GAL) enzyme, leading to…”
Get full text

Renal effects of maintenance low-dose cyclosporin A treatment in psoriasis by Svarstad, E, Helland, S, Morken, T, Bostad, L, Myking, A, Iversen, B M, Ofstad, J

“…The renal effects of low-dose cyclosporin A (CsA) treatment in severe psoriasis was investigated in 10 patients treated with a mean CsA dose of 3.23 (range…”
Get more information

Salt sensitivity in hypertensive type-1 diabetes mellitus by Gerdts, E, Svarstad, E, Myking, O L, Lund-Johansen, P, Omvik, P

“…As sodium retention has been proposed as a causal factor in the development of hypertension in diabetic patients, a high incidence of salt sensitivity has been…”
Get more information

Monitoring renal function in children with Fabry disease: comparisons of measured and creatinine-based estimated glomerular filtration rate by TØNDEL, Camilla, RAMASWAMI, Uma, MOBERG AAKRE, Kristin, WIJBURG, Frits, BOUWMAN, Machtelt, SVARSTAD, Einar

“…Studies on renal function in children with Fabry disease have mainly been done using estimated creatinine-based glomerular filtration rate (GFR). The aim of…”
Get full text

CR1 activity on erythrocytes and renal glomeruli in patients with renal disorders by Iversen, B M, Vedeler, C A, Matre, R, Svarstad, E

“…Complement receptors for C3b/C4b (CRI) on erythrocytes (ERC1) and renal glomeruli (GCR1) were examined in patients with different types of renal disorders…”
Get more information

Nephropathy in Fabry disease: the importance of early diagnosis and testing in high-risk populations by Öqvist, Björn, Brenner, Barry M., Oliveira, João Paulo, Ortiz, Alberto, Schaefer, Roland, Svarstad, Einar, Wanner, Christoph, Zhang, Kate, Warnock, David G.

Get full text

Glomerular hemodynamics in progressive renal disease by Ofstad, J, Horvei, G, Kvam, F I, Mørkrid, L, Sekse, I, Svarstad, E, Iversen, B M

“…A descriptive survey of renal hemodynamics in the major experimental models of progressive renal disorders (primary loss of renal tissue, primary glomerular…”
Get more information

Kinetic basis of hyperhomocysteinemia in patients with chronic renal failure by Guttormsen, Anne B., Ueland, Per M., Svarstad, Einar, Refsum, Helga

“…Kinetic basis of hyperhomocysteinemia in patients with chronic renal failure. We investigated the elimination of total homocysteine (tHcy) from plasma after…”
Get full text